BRIEF published on 03/12/2026 at 21:20, 6 months 17 days ago Nanobiotix Announces Voting Rights and Share Capital Details Euronext Paris Share Capital Voting Rights Nasdaq NANOBIOTIX
PRESS RELEASE published on 03/12/2026 at 21:15, 6 months 17 days ago Voting Rights and Shares Capital of the Company Nanobiotix discloses voting rights and shares capital details as of February 28, 2026, on Euronext Paris and Nasdaq markets. Learn about their disruptive therapeutic approaches and global presence Euronext Paris Voting Rights Nasdaq Shares Capital NANOBIOTIX
BRIEF published on 02/25/2026 at 22:20, 7 months 4 days ago NANOBIOTIX Presents at Key Conferences in March Biotechnology Investor Conferences Cancer Treatments NANOBIOTIX Clinical Advances
BRIEF published on 02/25/2026 at 22:20, 7 months 4 days ago NANOBIOTIX Présente à des Conférences Clés en Mars Biotechnologie Conférences Investisseurs NANOBIOTIX Avancées Cliniques Traitements Cancer
PRESS RELEASE published on 02/25/2026 at 22:15, 7 months 4 days ago NANOBIOTIX participera à plusieurs conférences investisseurs en mars Nanobiotix participera à plusieurs conférences investisseurs en mars. Détails sur les événements et les participants. La société présentera ses approches novatrices en biotechnologie Biotechnologie Cancer Conférences Investisseurs NANOBIOTIX Approches Therapeutiques
BRIEF published on 02/17/2026 at 22:20, 7 months 12 days ago Nanobiotix Announces Updated Voting Rights and Share Capital Euronext Paris Voting Rights Shares Capital Financial Disclosure NANOBIOTIX
BRIEF published on 02/17/2026 at 22:20, 7 months 12 days ago Nanobiotix annonce une mise à jour de ses droits de vote et de son capital social Euronext Paris Capital Social Droit De Vote Divulgation Financière NANOBIOTIX
PRESS RELEASE published on 02/17/2026 at 22:15, 7 months 12 days ago Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social Nanobiotix publie son information mensuelle sur les droits de vote et actions. La société développe des traitements innovants en biotechnologie Droits De Vote Biotechnologie Actions Traitements NANOBIOTIX
PRESS RELEASE published on 02/17/2026 at 22:15, 7 months 12 days ago Voting Rights and Shares Capital of the Company Nanobiotix discloses voting rights and shares capital. The biotech company is listed on Euronext Paris and Nasdaq, focusing on disruptive therapies Euronext Paris Voting Rights Nasdaq Shares Capital NANOBIOTIX
BRIEF published on 02/02/2026 at 09:44, 7 months 28 days ago Goldman Sachs réduit sa participation dans Nanobiotix Euronext Paris Franchissement De Seuil Goldman Sachs Cession D'actions NANOBIOTIX
Published on 09/30/2026 at 15:50, 1 hour 14 minutes ago Innodata Opens Motion-Capture AI Lab to Help Humanoids Move Like Humans
Published on 09/30/2026 at 14:37, 2 hours 27 minutes ago NuRAN Leverages Starlink Backhaul to Drive Higher Revenue Per Rural Site
Published on 09/30/2026 at 14:31, 2 hours 33 minutes ago First Breach Expands Ammunition Manufacturing Operations to Seven Days a Week
Published on 09/30/2026 at 14:07, 2 hours 57 minutes ago Worksport COR Energy System Now Available Through Amazon
Published on 09/30/2026 at 13:30, 3 hours 34 minutes ago Nextech3D.ai Engages MZ Group to Lead Strategic Investor Relations Program
Published on 09/30/2026 at 16:32, 31 minutes ago VVV Sports Limited: Interim Results for the six months ended 30 June 2026
Published on 09/30/2026 at 16:30, 34 minutes ago Original-Research: HORNBACH Holding AG & Co. KGaA (von Quirin Privatbank Kapitalmarktgeschäft): Buy
Published on 09/30/2026 at 16:20, 44 minutes ago EQS-Adhoc: MS Industrie AG: MS XTEC acquires a 51% majority stake in IDAS d.o.o., Mol, Serbia
Published on 09/30/2026 at 16:00, 1 hour 4 minutes ago Piramal Pharma Solutions and NP2 to Complete Cyclophosphamide Development Phase Next Month
Published on 09/30/2026 at 15:41, 1 hour 23 minutes ago Branicks Group AG 2026 Half-Year Report: Steady Operational Progress, Key Structural Changes Implemented
Published on 09/30/2026 at 12:14, 4 hours 50 minutes ago Mise à disposition du rapport financier semestriel au 30 juin 2026
Published on 09/30/2026 at 12:00, 5 hours 4 minutes ago Kapitaalverhoging door uitoefening van inschrijvingsrechten
Published on 09/30/2026 at 12:00, 5 hours 4 minutes ago Capital increase through exercise of subscription rights
Published on 09/30/2026 at 08:45, 8 hours 19 minutes ago Air Liquide invests over 170 million euros to support a semiconductor leader expanding manufacturing capabilities in Japan
Published on 09/30/2026 at 08:45, 8 hours 19 minutes ago Air Liquide investit plus de 170 millions d’euros pour accompagner un leader des semi-conducteurs dans le développement de ses capacités de production au Japon
